CXCL9 as a biomarker for disease activity in patients with morphea

被引：1

作者：

Florez-Pollack, S. ^{[1
]}

O'Brien, J. C. ^{[1
]}

Jacobe, H. T. ^{[1
]}

机构：

[1] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2018年 / 138卷 / 05期

关键词：

D O I：

10.1016/j.jid.2018.03.456

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

449

引用

页码：S76 / S76

页数：1

共 50 条

[31] Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury
Hricik, D. E.
Nickerson, P.
Formica, R. N.
Poggio, E. D.
Rush, D.
Newell, K. A.
Goebel, J.
Gibson, I. W.
Fairchild, R. L.
Riggs, M.
Spain, K.
Ikle, D.
Bridges, N. D.
Heeger, P. S.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (10) : 2634 - 2644
[32] Increased serum levels of CCL3, CXCL8, CXCL9, and CXCL10 in rosacea patients and their correlation with disease severity
Liu, Tangxiele
Li, Ji
Deng, Zhili
Chen, Mengting
Sha, Ke
Xiao, Wenqin
Xie, Hongfu
Zhao, Zhixiang
JOURNAL OF DERMATOLOGY, 2022, 49 (05): : 525 - 533
[33] Intragraft transcriptome level of CXCL9 as biomarker of acute cellular rejection after liver transplantation
Asaoka, Tadafumi
Marubashi, Shigeru
Kobayashi, Shogo
Hama, Naoki
Eguchi, Hidetoshi
Takeda, Yutaka
Tanemura, Masahiro
Wada, Hiroshi
Takemasa, Ichiro
Takahashi, Hidenori
Ruiz, Phillip
Doki, Yuichiro
Mori, Masaki
Nagano, Hiroaki
JOURNAL OF SURGICAL RESEARCH, 2012, 178 (02) : 1003 - 1014
[34] The Role of CXCL13 and CXCL9 in Early Breast Cancer
Razis, Evangelia
Kalogeras, Konstantine T.
Kotsantis, Ioannis
Koliou, Georgia-Angeliki
Manousou, Kyriaki
Wirtz, Ralph
Veltrup, Elke
Patsea, Helen
Poulakaki, Nikiforita
Dionysopoulos, Dimitrios
Pervana, Stavroula
Gogas, Helen
Koutras, Angelos
Pentheroudakis, George
Christodoulou, Christos
Linardou, Helena
Pavlakis, Kitty
Koletsa, Triantafyllia
Pectasides, Dimitrios
Zagouri, Flora
Fountzilas, George
CLINICAL BREAST CANCER, 2020, 20 (01) : E36 - E53
[35] CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
Kuan, Woon Pang
Tam, Lai-Shan
Wong, Chun-Kwok
Ko, Fanny W. S.
Li, Tena
Zhu, Tracy
Li, Edmund K.
JOURNAL OF RHEUMATOLOGY, 2010, 37 (02) : 257 - 264
[36] CXC Chemokines CXCL1, CXCL9, CXCL10 and CXCL12 are Variably Expressed in Patients with Sickle Cell Disease and Carriers: Are They Predictive Tools for Disease Complications?
Ostadebrahimi, Hamid
Jamali, Zahra
Nazari, Mahmood
Bahri, Mina
Farahmandnia, Zahra
Khandany, Behjat Kalantary
Taheri, Mohsen
Khorramdelazad, Hosssein
Hakimizadeh, Elham
Zaker, Farhad
Rezaeian, Mohsen
Hassanshahi, Gholamhossein
CLINICAL LABORATORY, 2014, 60 (01) : 99 - 104
[37] Differential expression of CXCL9, CXCL10, and IFN-γ in vitiligo and alopecia areata patients
Maouia, Amal
Sormani, Laura
Youssef, Monia
Helal, Ahmed N.
Kassab, Asma
Passeron, Thierry
PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (02) : 259 - 261
[38] The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjögren's syndrome
Hakbilen, Selda
Tezcan, Dilek
Onmaz, Duygu Eryavuz
Yilmaz, Sema
Korez, Muslu Kazim
Unlu, Ali
CLINICAL RHEUMATOLOGY, 2025, : 1635 - 1642
[39] Overproduction of CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 in β-thalassemia major or patients
Najmaddini, Hamid
Hassanshahi, Gholamhossein
Ostadebrahimi, Hamid
Barkhordari, Hoda
Mashayekhi, Habibeh
Nazari, Mina
Moogooei, Mozhgan
Arababadi, Yassin Safari
Peighambari, Fatemeh
Karimabad, Mojgan Noroozi
ANNALS OF SAUDI MEDICINE, 2014, 34 (02) : 122 - 127
[40] Circulating CXCL9 and CXCL10 as Markers of Activity of Graves' Orbitopathy During Treatment with Corticosteroids and Teleradiotherapy
Mysliwiec, J.
Palyga, I.
Kosciuszko, M.
Kowalska, A.
Gorska, M.
HORMONE AND METABOLIC RESEARCH, 2012, 44 (13) : 957 - 961

← 1 2 3 4 5 →